We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+12.58%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$24B
AUM Growth
+$1.56B
(+6.9%)
Cap. Flow
-$931M
Cap. Flow
% of AUM
-3.87%
Top 10 Holdings %
Top 10 Hldgs %
25.33%
Holding
2,059
New
128
Increased
454
Reduced
915
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$36.7M |
| 2 |
VICI Properties
VICI
|
+$32.5M |
| 3 |
Elevance Health
ELV
|
+$27.3M |
| 4 |
Arch Capital
ACGL
|
+$24.7M |
| 5 |
Kite Realty
KRG
|
+$24.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$55.4M |
| 2 |
Apple
AAPL
|
+$48.9M |
| 3 |
Synopsys
SNPS
|
+$44.7M |
| 4 |
Netflix
NFLX
|
+$40.2M |
| 5 |
Markel Group
MKL
|
+$35.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.86% |
| 2 | Financials | 12.81% |
| 3 | Healthcare | 12.06% |
| 4 | Consumer Discretionary | 10.3% |
| 5 | Industrials | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Manhattan Associates
MANH
$8.97B
| $7.52M | 0.03% |
34,912
+3,778
| +12% | +$800K |
|
402
Akamai
AKAM
$16.8B
| $7.38M | 0.03% |
62,349
+6,545
| +12% | +$728K |
|
403
ICF International
ICFI
$1.44B
| $7.35M | 0.03% |
54,816
+7,100
| +15% | +$933K |
|
404
Broadridge
BR
$17.2B
| $7.32M | 0.03% |
35,571
+9,071
| +34% | +$1.67M |
|
405
Healthcare Realty
HR
$7.42B
| $7.28M | 0.03% |
422,508
-91,856
| -18% | -$1.4M |
|
406
Pultegroup
PHM
$24.5B
| $7.21M | 0.03% |
69,897
-6,894
| -9% | -$586K |
|
407
CONMED
CNMD
$1.29B
| $7.09M | 0.03% |
64,791
+3,200
| +5% | +$331K |
|
408
Selective Insurance
SIGI
$5.74B
| $7.08M | 0.03% |
71,200
+5,400
| +8% | +$554K |
|
409
Cousins Properties
CUZ
$5.29B
| $7.02M | 0.03% |
288,379
-53,070
| -16% | -$1.09M |
|
410
Ares Management
ARES
$28.5B
| $6.99M | 0.03% |
58,798
-1,020
| -2% | -$111K |
|
411
UMB Financial
UMBF
$10.7B
| $6.98M | 0.03% |
83,500
+79,200
| +1,842% | +$5.57M |
|
412
Applied Industrial Technologies
AIT
$12.8B
| $6.94M | 0.03% |
40,200
+400
| +1% | +$64.8K |
|
413
Camden Property Trust
CPT
$11.3B
| $6.9M | 0.03% |
69,499
-1,600
| -2% | -$148K |
|
414
SBA Communications
SBAC
$18.4B
| $6.87M | 0.03% |
27,100
+3,700
| +16% | +$831K |
|
415
Ameriprise Financial
AMP
$46.8B
| $6.84M | 0.03% |
18,000
| – | – |
|
|
SGI
416
Somnigroup International
SGI
$15.1B
| $6.76M | 0.03% |
132,700
-18,928
| -12% | -$803K |
|
417
Texas Roadhouse
TXRH
$12.7B
| $6.74M | 0.03% |
55,181
+7,706
| +16% | +$823K |
|
418
Houlihan Lokey
HLI
$9.68B
| $6.68M | 0.03% |
55,700
+5,700
| +11% | +$618K |
|
419
Littelfuse
LFUS
$10.2B
| $6.6M | 0.03% |
24,662
-7,670
| -24% | -$1.84M |
|
|
CYBR
420
DELISTED
CyberArk
CYBR
| $6.59M | 0.03% |
30,100
+14,700
| +95% | +$2.73M |
|
421
Assurant
AIZ
$13.7B
| $6.57M | 0.03% |
38,999
+23,520
| +152% | +$3.74M |
|
422
Repligen
RGEN
$7.44B
| $6.53M | 0.03% |
36,300
+2,400
| +7% | +$374K |
|
423
Teva Pharmaceuticals
TEVA
$35.9B
| $6.46M | 0.03% |
618,894
+956
| +0.2% | +$8.93K |
|
424
ResMed
RMD
$28.3B
| $6.45M | 0.03% |
37,500
-61,000
| -62% | -$9.37M |
|
425
KBR
KBR
$4.68B
| $6.44M | 0.03% |
116,303
+26,779
| +30% | +$1.48M |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q4 2023 Portfolio in Review
As of Q4 2023, STRS Ohio held 2,059 positions worth $24B, up 6.9% from $22.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
STRS Ohio withdrew a net $931M in Q4 2023, closing 153 positions and reducing 915 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $55.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
Against the trend, STRS Ohio opened a new position in Synovus worth $16.4M.
- STRS Ohio's largest Q4 2023 buy was Synovus: 436,000 shares worth $16.4M.
- STRS Ohio added most to Broadcom in Q4 2023, an estimated $36.7M increase.
- STRS Ohio's biggest Q4 2023 reduction was Apple, cutting an estimated $48.9M.
- STRS Ohio fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $55.4M.
- STRS Ohio's ten largest holdings make up 25% of its $24B portfolio in Q4 2023.
- STRS Ohio opened 128 new positions and closed 153 in Q4 2023.
- STRS Ohio's portfolio value rose 6.9% quarter-over-quarter to $24B.
Based on STRS Ohio's 13F filing for Q4 2023, filed 30 Jan 2024.